Surgical Management of Cranial Base Metastases

Author:

Chamoun Roukoz B.1,Suki Dima1,DeMonte Franco1

Affiliation:

1. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Abstract

Abstract BACKGROUND: Cranial base metastases (CBM) are rare and have received limited attention in the medical literature. Questions remain regarding the role of surgery, if any, in the management of these tumors. OBJECTIVE: To report surgical outcomes in a consecutive series of patients with CBM and to better define the role of surgery in their management. METHODS: Twenty-seven patients with CBM underwent surgery between 1996 and 2009 at MD Anderson Cancer Center. A retrospective review of their prospectively collected data was performed after obtaining institutional review board approval. The median patient age was 52 years. The most common pathology was renal cell carcinoma (6 patients). Surgical indications were worsening neurological deficit, disfiguring mass, and the need for a diagnosis. RESULTS: Gross total resection was achieved in 59% of the cases. The median survival was 11.4 months. The median progression-free survival was 5.8 months. A Karnofsky Performance Scale score less than 90, dural invasion, and brain invasion were associated with a shorter survival. Seven patients were neurologically intact preoperatively; all of them remained intact after surgery. Among all patients with preoperative neurological deficit, 11 remained stable, 7 improved, and 2 had worsening of their deficit postoperatively. CONCLUSION: The goal of surgery for CBM is to provide symptom relief and to preserve functional status in well-selected cases. Patient selection is critical because the surgery is usually palliative, and only a minority of patients are surgical candidates. Radiation therapy remains the management option of choice for the majority of patients.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Reference15 articles.

1. Current concepts in the management of tumors of the skull base;Morita;Cancer Control,1998

2. Skull-base metastases;Laigle-Donadey;J Neurooncol,2005

3. Metastasis to the base of the skull: clinical findings in 43 patients;Greenberg;Neurology,1981

4. Metastatic tumours of the temporal bone;Belal;A histopathological report. J Laryngol Otol,1985

5. Primary and secondary tumors of the facial nerve;Jung;A temporal bone study. Arch Otolaryngol Head Neck Surg,1986

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. New Daily Persistent Headache (NDPH): Unraveling the Complexities of Diagnosis, Pathophysiology, and Treatment;Current Pain and Headache Reports;2023-08-26

2. Neoplastic nerve lesions;Neurological Sciences;2022-02-23

3. Management considerations for malignant tumors of the skull base;Journal of Neuro-Oncology;2020-10-09

4. Management of Skull Base Metastases;Neurosurgery Clinics of North America;2020-10

5. A Time-Tested Information System in Neurosurgical Oncology;Frontiers in Oncology;2018-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3